Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)
Clinical trial NCT02023879 · COMPLETED
Trial details
- NCT number
- NCT02023879
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-16
- Primary completion
- 2014-10-27
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.